AGBL participated in the The First World Congress in Artificial Gametogenesis

Alliance Global spent an exciting day at the Rosewood Hotel in Abu Dhabi to participate in The First World Congress in Artificial Gametogenesis held from the 9th – 10th October, under the patronage of the Lt. General H.H Sheik Saif bin Zayed Al Nahyan, Deputy Prime Minister, Minister of Interior and in partnership with Al Ain Fertility Center and Khalifa University.

The event presented the state-of-the-art techniques in Artificial Gametogenesis. The event summarized current experiences from different researchers in this field, and discussed the feasibility for Artificial Gametogenesis in Humans.

The First World Congress in Artificial Gametogenesis hosted a diverse range of visitors – mainly Gynecologists, Obstetricians, Specialty Physicians in the field of IVF, Medical Practitioners, Geneticians, Researchers and also Students.

The meeting served as a superb platform for Physicians and Medical Specialists to share best practices and experiences and to network with new and established colleagues, creating and strengthening clinical collaborations.

Alliance Global (AGBL) gives a talk at the prestigious King Faisal Specialist Hospital & Research Centre

Alliance Global is excited to participate at the Seminar on Next Generation Sequencing – Clinical Applications in Oncology, to be held in King Faisal Specialist Hospital & Research Centre, Riyadh Saudi Arabia on the 21st of September 2017.

Dr. Yusuf Murgha, Application Scientist, will be representing AGBL at this event by giving a talk on “Routine genetic testing for cancer predisposition, diagnostics & monitoring therapeutics”

Speaker: Dr. Yusuf Murgha
Dr. Yusuf Murgha had done his PhD in Biomedical Engineering at the University of Michigan, USA. He specialized in developing methods to add value to microarray oligonucleotides pools. He later went on to join companies such as MYcroarray where he lead the development of oligonucleotide pools for cytogenetic assays and DNA oligonucleotide synthesis. In 2015, he joined Genotypic, India as
the NGS wet lab manager where he gained extensive experience in all aspect of lab management. Dr. Murgha has experience running an NGS core service lab offering multiple DNA and RNA applications on Illumina and Ion Torrent platforms. He has 4 methods publications for the development of NGS reagent kits.

Alliance Global (AGBL)
The AGBL Group of companies is the largest biomedical gateway to the emerging markets of the Middle East, Africa and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets within the MENA region. The group employs dedicated teams of product and applications specialists, and has many offices across the region offering distribution, consulting and product development services to world-renowned manufacturers of biomedical technologies. The group’s stated mission is to improve the lives of the region’s inhabitants through novel biomedical technologies and products.

GenePeeks and Alliance Global Group (AGBL) Sign Distribution Agreement for Middle East and Africa

genepeeks-logoAlliance Global Group (AGBL) partners with Genepeeks to bring their innovative solutions for comprehensive preconception screening to patients, healthcare providers and laboratories in the Middle Eastern and African regions.

Dr. Tamer Degheidy, Group CEO at Alliance Global stated, “GenePeeks Preconception Screen is an important addition to our growing portfolio of genetic tests, and we’re excited to offer this comprehensive, state-of-the art approach, which reduces the population biases that are associated with traditional carrier screening. It is the first step in our shared mission to transform gene-based clinical applications using GenePeeks’ core technology platform.”

“We are honored to partner with Alliance Global to address the significant unmet need in these markets for comprehensive preconception screening,” said Anne Morriss, Co-Founder and Chief Executive Officer of GenePeeks. “AGBL’s regional breadth and market knowledge, combined with the analytic power of our advanced computational platform, will give more prospective parents the information and support they need to protect their future families. AGBL is another strong partner for our growing presence outside of the U.S.”

Read the entire Press Release here.

Alliance Global was a sponsor at the 10th H3 Africa Consortium Meetings

Alliance Global was a sponsor this year at the 10th H3 Africa Consortium Meetings which was held in Gaborone, Botswana from the 12th – 15th of May at the Grand Palm Hotel Casino Convention Resort. The goal of the H3 Africa initiative is to facilitate a contemporary research approach to the study of the genomic and environmental determinants of common diseases in Africa, with the purpose of improving the health of African populations. Raksha Toolsi – Senior Sales Specialist for AGBL Sub Sahara was at the event representing Alliance Global as an exhibitor.

Cell Signaling Technology and Alliance Global Group sign an exclusive distribution agreement

Dubai 15th March 2017,

CELL SIGNALING TECHNOLOGIES (USA) signed an exclusive distribution agreement with Alliance Global to bring their highest quality antibody portfolio to AGBL’s market.
“Cell Signaling Technology high-quality, reproducible antibodies will allow scientists in the field of protein and cell biology to optimize their research and save valuable time,” said Fatima Kakal, Product Manager Cell and Molecular Biology Division at Alliance Global Group.

About Cell Signaling Technology
Cell Signaling Technology (CST), head quartered in USA, is a private, family-owned company, founded by scientists and dedicated to providing the world’s highest quality, innovative research and diagnostic products to accelerate biological understanding and enable personalized medicine. In addition to product development and production, CST is also actively engaged in the development of new technologies for signaling analysis as well as mechanistic cell biology research. For more information, please visit

Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future uses, quality or performance of, or benefits of using, products or technologies, the expected benefits of the agreement between AGBL and Cell Signaling Technologies and other future events.
AGBL undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.

Alliance Global will be participating in the 9th edition of Obs-Gyne Exhibition & Congress, Dubai

Alliance Global will be participating in the 9th edition of Obs-Gyne Exhibition & Congress. The conference is CME accredited and is the regions only show for women’s health professionals, it will be held from the 19th – 21st of April at the Dubai International Convention & Exhibition Center. The event will cover the management and prevention of chronic diseases pregnancy, the latest the latest updates in the detection and treatment of gyneoncologic disorders, the latest surgical techniques for the management of a range of gynaecologic disorders, evaluation of current and evidence-based approaches to managing menopause, appraisal of the latest clinical research and improve patient outcomes in reproductive health issues.

Customer Testimonial

Azure C200 has great performance in order to visualize your gel. The system has built in L.E.D lights and separated U.V light to get the perfect image. The system also has built in L.C.D tablet and the software where you can retrieve your gel data. Also the system can be connected to the separate PC for the software analysis. The system gives you quick visualization of gel and reading in less than 5 seconds. You can also adjust the light in order to get a perfect view. With the experience of more than 2 years on Azure C200, I strongly recommend this unit for diagnostic and research purpose.

Faizan Raza
Molecular Section Head , Dow Diagnostics FZ LLC, Dubai, UAE

CelltraZone and Alliance Global Group sign an exclusive distribution agreement

Dubai, 26th January 2017
CelltraZone signed an exclusive distribution agreement with the AGBL Group (Dubai, UAE) to bring their innovative Liquid-Based Cytology Slide Processors to the MEA markets.

“CelltraZone’ s patented solutions and filters will allow pathologists to have a higher quality smears for diagnosis of cancer cells in Gynaecological and Non-Gynaecological samples, we think it will be a great addition to our laboratories in the region”, said Nisreen Haddadin, Product Manager at Alliance Global.
About CelltraZone

CelltraZone is a Korean company, established in 2007 as the manufacturer of Liquid Base Cytology (LBC) Systems. CelltraZone is focusing all their efforts toward contributing to the health of people through supplying advanced products of high quality in the cytological diagnosis field. CelltraZone have succeeded in achieving the high qualities of smearing with speed, convenience and simplicity of processing and compactness of the processor with very low prices. All CelltraZone products are manufactured and supplied within the framework of a Quality Management System accredited to EN ISO 13485:2012.

More information is available at-
Please email us at for more details.

Alliance participated in the 2nd Upper Egypt Assisted Reproductive Conference 2017 in Cairo, Egypt

Alliance global participated in the The 2nd Upper Egypt Assisted Reproductive Conference 2017 in Cairo Egypt from the 22nd – 24th of Feb 2017. UEARS 2017 main theme was Translational Research in ART: Basic Science to Improve Clinical Practice. As the theme implies, it explored the reciprocation of ground breaking notions in the field of “Assisted Reproduction” with iconic mixture between International & Egyptian scholars.
The Conference featured leading state of The Art Lectures from KOL scientists, plenary lectures, interdisciplinary symposia, workshops, Hands-on, oral and poster sessions for all the participants to facilitate discussions on diagnosis; improve access and quality care; optimize the coordination of service providers; and foster high impact clinical research to expedite improved medical treatments. The conference mainly aimed at the education of the medical community and dissemination of reliable information to at-risk populations

The 2nd Upper Egypt Assisted Reproductive Conference 2017

Alliance Global participated in the 31st HPV Conference 2017 in Cape Town, South Africa

Alliance Global participated in the 31st International Human Papilloma Virus Conference which was held in Cape Town, South Africa from the 28th Feb – 4th March 2017.
The conference covered papilloma virus (PV)-related topics from basic science to global health impact. In line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, conference themes included the epidemiology and molecular biology of PVs; animal models for the study of papillomaviral disease; impact of the microbiome on HPV; basic immunology and pathogenesis of PVs; therapeutic and prophylactic vaccines; prevention of cervical cancer and other PV-associated diseases, and promotion of the spread of the scientific knowledge to benefit the whole community.



Alliance Global will be at Arab Health 2017

Arab Health is the largest gathering of healthcare and trade professionals in the MENA region. It will be taking place from the 30th of January to the 2nd of February 2017 at the Dubai International Convention and Exhibition Center, UAE. Come visit us at booth number Z2.B70 at Za’abeel Hall 4, we look forward to seeing you at the event.

Alliance Global is participating as a gold sponsor at MEDLAB 2017

MEDLAB 2017 will be held from the 6th – 9th of February at the Dubai International Convention & Exhibition Center. This year alliance global is one of the gold sponsors at the event, visit us at our booth Z4.E40, Za’abeel Hall 4.
The MEDLAB Middle East flagship event has established itself as one of the largest laboratory exhibitions in the world and has the largest number of conference delegates globally.
The 2017 edition of MEDLAB takes place from 6th-9th February and will feature over 400 cutting-edge laboratory technologies being showcased from over 700 exhibitors from 38 countries, expecting to welcome over 30,000 laboratory and trade professionals from all continents. During the four-day event, 11 multi-disciplinary conferences offer up to 28 CME credits that will be led by globally recognized speakers on topics including laboratory management, microbiology and immunology, and clinical chemistry. While incorporating new tracks specializing in blood transfusion medicine, laboratory informatics and updates in clinical diagnostics of cardiology and diabetes enabling the correlation of roles between laboratory professionals and clinicians. Delegates can also attend a number of workshops led by globally leading laboratory management and diagnostics companies. The workshops will cover a variety of areas including pediatric pathology and lab accreditation.
Visit for more information.